Answers about your abnormal Pap test
Very few experiences can be as frightening as receiving a call that your pap smear came back abnormal. Although cervical cancer is the first thing that may comes to mind, most of the time an abnormal pap smear indicates a minor problem with the cervix that may or may not need treatment.
Visit Dr. Indman's award winning web sites: Alternatives in Gynecology and Fibroid Medical Center of Northern California
Very few experiences can be as frightening as receiving a call that your pap smear came back abnormal. Although cervical cancer is the first thing that may comes to mind, most of the time an abnormal pap smear indicates a minor problem with the cervix that may or may not need treatment.
What is the Pap test?
During a pap smear some cells are scraped or brushed off the cervix, and prepared on a slide that can be examined under a microscope. The purpose of the Pap test is to detect changes that may lead to cervical cancer long before cancer develops. Pre-cancer of the cervix is easily treated, and almost always prevents cancer from developing.
Classification of Pap Tests
There have been many classifications of pap tests, leading to a great deal of confusion. It is much simpler to think of the pap smear as showing one of several things:
- Normal, or a variation of normal, such as "irritation"
- Probably normal, but there are mild changes that you should keep an eye on or evaluate further
- Pre-cancerous changes
- Invasive cancer
No matter which classification system is being used, all pap smear reports can be thought of as belonging to one of the above groups.
Years ago pap smears were graded on a scale from 1 to 5, with 1 being normal and 5 being cancer. There was little agreement between labs of what the numbers meant. Although this classification system is obsolete, some labs unfortunately still use this reporting system.
In order to understand how pap tests are classified, you first need to know a little more about the cervix.
Copyright © 1998 Paul D. Indman, M.D.
References:
Copyright © 1998 Paul D. Indman, M.D.
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More
Offering cervical and colorectal cancer screening at breast cancer screening found effective
August 26th 2024In a recent study, women overdue for cervical cancer and colorectal cancer screening were more likely to receive coverage when offered during their breast cancer screening visit.
Read More
